Multidisciplinary team care in advanced lung cancer
2020 Translational Lung Cancer Research. All rights reserved..
Lung cancer is the most common cause of cancer mortality globally. A vast majority of lung cancer cases are diagnosed at advanced stages. Management of advanced lung cancer requires several diagnostic and therapeutic procedures provided by various specialists. To optimise the entire diagnostic and therapeutic process, a concept of care provided simultaneously by a multidisciplinary team (MDT) has been developed and implemented in specialised centres worldwide. Observational studies suggest that integrated and coordinated care increases adherence to clinical guidelines, significantly shortens the interval from diagnosis to treatment, and may increase survival and quality of life (QoL). Prospective studies are warranted to assess the real impact of MDT on treatment outcomes and to further refine this approach.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Translational lung cancer research - 9(2020), 4 vom: 16. Aug., Seite 1690-1698 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kowalczyk, Anna [VerfasserIn] |
---|
Links: |
---|
Themen: |
Diagnosis |
---|
Anmerkungen: |
Date Revised 28.09.2020 published: Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.21037/tlcr.2019.11.33 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM315248815 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM315248815 | ||
003 | DE-627 | ||
005 | 20231225154511.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.21037/tlcr.2019.11.33 |2 doi | |
028 | 5 | 2 | |a pubmed24n1050.xml |
035 | |a (DE-627)NLM315248815 | ||
035 | |a (NLM)32953542 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kowalczyk, Anna |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multidisciplinary team care in advanced lung cancer |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.09.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a 2020 Translational Lung Cancer Research. All rights reserved. | ||
520 | |a Lung cancer is the most common cause of cancer mortality globally. A vast majority of lung cancer cases are diagnosed at advanced stages. Management of advanced lung cancer requires several diagnostic and therapeutic procedures provided by various specialists. To optimise the entire diagnostic and therapeutic process, a concept of care provided simultaneously by a multidisciplinary team (MDT) has been developed and implemented in specialised centres worldwide. Observational studies suggest that integrated and coordinated care increases adherence to clinical guidelines, significantly shortens the interval from diagnosis to treatment, and may increase survival and quality of life (QoL). Prospective studies are warranted to assess the real impact of MDT on treatment outcomes and to further refine this approach | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Multidisciplinary care | |
650 | 4 | |a diagnosis | |
650 | 4 | |a lung cancer | |
650 | 4 | |a treatment | |
700 | 1 | |a Jassem, Jacek |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Translational lung cancer research |d 2012 |g 9(2020), 4 vom: 16. Aug., Seite 1690-1698 |w (DE-627)NLM24739839X |x 2218-6751 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2020 |g number:4 |g day:16 |g month:08 |g pages:1690-1698 |
856 | 4 | 0 | |u http://dx.doi.org/10.21037/tlcr.2019.11.33 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2020 |e 4 |b 16 |c 08 |h 1690-1698 |